CN109744449A - A kind of increasing flesh solid beverage - Google Patents
A kind of increasing flesh solid beverage Download PDFInfo
- Publication number
- CN109744449A CN109744449A CN201910110553.5A CN201910110553A CN109744449A CN 109744449 A CN109744449 A CN 109744449A CN 201910110553 A CN201910110553 A CN 201910110553A CN 109744449 A CN109744449 A CN 109744449A
- Authority
- CN
- China
- Prior art keywords
- solid beverage
- beta
- parts
- increasing
- sweetener
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 46
- 239000007787 solid Substances 0.000 title claims abstract description 46
- 239000000843 powder Substances 0.000 claims abstract description 32
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 31
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 24
- 240000008042 Zea mays Species 0.000 claims abstract description 23
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 23
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 23
- 235000005822 corn Nutrition 0.000 claims abstract description 23
- 239000005862 Whey Substances 0.000 claims abstract description 20
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 19
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 19
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 12
- 239000003765 sweetening agent Substances 0.000 claims abstract description 12
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 14
- 239000004376 Sucralose Substances 0.000 claims description 14
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims description 14
- 235000019408 sucralose Nutrition 0.000 claims description 14
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 14
- 235000021119 whey protein Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 8
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 8
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 8
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 7
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 7
- 229960000310 isoleucine Drugs 0.000 claims description 7
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 7
- 239000004474 valine Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 102000004407 Lactalbumin Human genes 0.000 claims description 5
- 108090000942 Lactalbumin Proteins 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 229960004998 acesulfame potassium Drugs 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000007902 hard capsule Substances 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 229940100688 oral solution Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000007423 decrease Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 108010011485 Aspartame Proteins 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- YZHOZVWZUXBPMD-UHFFFAOYSA-N calcium;3-hydroxy-3-methylbutanoic acid Chemical compound [Ca].CC(C)(O)CC(O)=O YZHOZVWZUXBPMD-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 230000004220 muscle function Effects 0.000 description 2
- 208000001076 sarcopenia Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000017434 Torsin Human genes 0.000 description 1
- 108050005633 Torsin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000007105 physical stamina Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a kind of increasing flesh solid beverages, the increasing flesh solid beverage includes following component: PURE WHEY, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl calcium butyrate, corn oligopeptide powder, sweetener, the solid beverage can be improved the leg speed of muscle decaying patient, grip, muscle ratios, to alleviate muscle decaying symptom.
Description
Technical field
The invention belongs to food technology fields, and in particular to a kind of solid beverage with muscle-increasing function.
Background technique
Office, China National Committee on Aging announces data and shows, China in 2014 60 years old and the above elderly population reach 2.12 hundred million,
The 15.5% of country's total population is accounted for, 60 years old 2017 and the above elderly population there are 2.41 hundred million people, account for total population 17.3%, growth becomes
Gesture is obvious, it is contemplated that before and after to the year two thousand fifty, China's elderly population number is up to peak value 4.87 hundred million, accounts for the 34.9% of total population.
Muscle decaying syndrome (sarcopenia) is a kind of, whole body of progressivity, popularity relevant to age growth
Skeletal muscle mass and function are lost, and merge physical stamina letdown, life quality reduces and the adverse events risk such as tumble and death increases
Clinical syndrome, it is closely related with other old-age group's property diseases.Muscle decaying syndrome lays particular emphasis on age-related muscle matter
Amount decline, the influence to health is various, such as makes the reduction of patient's resistance, sick to increase in hospital with dead probability.
Researches show that muscle function declines may start from one's mid-30s, and is declined with annual 1%~2% speed, 50
Decrease speed starts to accelerate after year, is in progress after 60 years old and accelerates, decrease speed reaches peak after 75 years old.In comparison, muscle function
Energy (strength and output power) decrease speed is more significant compared with quality decrease speed.The muscle decaying most important clinical manifestation of syndrome
For the decline of appendicular skeleton flesh quality and functionality, from 20 years old to 80 years old, individual muscle quality will reduce 30%, muscle fibre cross section
Product decline 20%.In general, aging with lower limb obviously in upper limb, extensor obviously in musculus flexor etc. significantly strength decline it is related, flesh
Significantly in volume, knee joint extensor strength falls to 55%~76% for the decline of meat strength.In addition, some patientss there is also
Breathe muscle group involvement, such as Chronic Obstructive Pulmonary Disease, patients with chronic congestive heart failure.
Muscle decaying syndrome is a kind of multifactorial disease of complexity, and generation and nutrition, hormone, metabolism, are immunized activity
Equal many factors are related, and patient can benefit from suitable multidisciplinary intervention mode, but nutrition and body movement are two weights
Factor is wanted, alleviating muscle decaying by way of nutritional intervention is preferable approach.
Lack currently on the market for the enteral nutrition product of " sarcopenia " patient, existing a few money products
It is not designed directed entirely to physiology, nutritional character and the demand of muscle decaying disease patient, cannot effectively improve patient battalion
Support undesirable condition.
Summary of the invention
In order to solve the above technical problems, the present invention provides a kind of increasing flesh solid beverages.
The technical solution adopted by the invention is as follows:
A kind of solid beverage with muscle-increasing function comprising following component: PURE WHEY, DEXTROSE ANHYDROUS, β-hydroxyl
Base-Beta-methyl calcium butyrate, corn oligopeptide powder, Sucralose.
A kind of increasing flesh solid beverage, it is characterised in that the every 100g of solid beverage includes the ingredient of following parts by weight: cream
50-75 parts of albumin powder, 15-30 parts of DEXTROSE ANHYDROUS, beta-hydroxy -5-15 parts of Beta-methyl calcium butyrate, corn oligopeptide powder 0.5-5
Part, 0.02-0.2 parts of Sucralose.
A kind of increasing flesh solid beverage, it is characterised in that the every 100g of solid beverage includes that ingredient and parts by weight are further
Are as follows: 60-70 parts of PURE WHEY, 20-25 parts of DEXTROSE ANHYDROUS, beta-hydroxy -5-10 parts of Beta-methyl calcium butyrate, corn oligopeptide powder
2-5 parts, 0.02-0.1 parts of Sucralose.
A kind of increasing flesh solid beverage, it is characterised in that the PURE WHEY is selected from concentrated whey protein powder, sepg whey
One of albumen powder, lactalbumin Gly-His-Lys are a variety of.
A kind of increasing flesh solid beverage, it is characterised in that the sweetener is selected from Sucralose, Aspartame peace or match honey.
A kind of increasing flesh solid beverage, it is characterised in that include branched-chain amino acid 2-4 parts in the solid beverage.
A kind of increasing flesh solid beverage, it is characterised in that the branched-chain amino acid is by leucine, valine and isoleucine group
At.
A kind of increasing flesh solid beverage, it is characterised in that leucine in the branched-chain amino acid: valine: the weight of isoleucine
Amount is than being 2: 1: 1.
A kind of preparation method of the solid beverage with muscle-increasing function, it is characterised in that: specific step is as follows:
(1) it is weighed by prescription and examines qualified PURE WHEY, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl calcium butyrate, corn
Oligomeric Gly-His-Lys, sweetener；
(2) sweetener, corn oligopeptide powder are uniformly mixed with beta-hydroxy-Beta-methyl calcium butyrate, are then passed according to equivalent
Increasing method be added DEXTROSE ANHYDROUS, PURE WHEY, be uniformly mixed, be distributed into bag to get.
A kind of preparation method of above-mentioned solid beverage with muscle-increasing function, it is characterised in that environment temperature 18- when mixing
25 DEG C, humidity≤50%.
Above-mentioned increasing flesh solid beverage usage and dosage: 1-2 times, 1 every time (5g/ item) daily.Be dissolved in about 200ml warm water,
Milk is eaten in meal.
Compared with prior art, the present invention has the advantage that and has the beneficial effect that:
1, the quality of protein is to construct the key factor of musculature, and the present invention selects concentrated whey protein powder, separation
The high-quality proteins such as PURE WHEY or lactalbumin Gly-His-Lys are nitrogen source, are more advantageous to the absorption and utilization of body, can be effective
Muscle decaying syndrome caused by torsin protein matter malnutrition.
2, it is added to creatine and beta-hydroxy-Beta-methyl calcium butyrate, the synthesis of muscle and the raising of muscle strength can be promoted.
3, skeletal muscle is the most active place of branched-amino acid metabolic, and the present invention can also add leucine, isoleucine etc.
The good protein of branched-chain amino acid, to be conducive to the synthesis of skeletal muscle.
Specific embodiment
The present invention provides a kind of increasing flesh solid beverage, to keep the purpose of the present invention, technical solution and effect clearer, bright
Really, the present invention is described in more detail below.It should be appreciated that specific embodiment described herein is only used to explain this hair
It is bright, it is not intended to limit the present invention.
Embodiment 1
(1) weighed by prescription examine qualified concentrated whey protein powder, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl calcium butyrate,
Corn oligopeptide powder, Sucralose；
(2) Sucralose, corn oligopeptide powder are uniformly mixed with beta-hydroxy-Beta-methyl calcium butyrate, then according to equivalent
Incremental method be added DEXTROSE ANHYDROUS, concentrated whey protein powder, be uniformly mixed, be distributed into bag to get.
Embodiment 2
(1) weighed by prescription examine qualified sepg whey albumen powder, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl calcium butyrate,
Corn oligopeptide powder, Sucralose；
(2) Sucralose, corn oligopeptide powder are uniformly mixed with beta-hydroxy-Beta-methyl calcium butyrate, then according to equivalent
Incremental method be added DEXTROSE ANHYDROUS, sepg whey albumen powder, be uniformly mixed, be distributed into bag to get.
Embodiment 3
(1) it is weighed by prescription and examines qualified lactalbumin Gly-His-Lys, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl calcium butyrate, jade
The oligomeric Gly-His-Lys of rice, Sucralose；
(2) Sucralose, corn oligopeptide powder are uniformly mixed with beta-hydroxy-Beta-methyl calcium butyrate, then according to equivalent
Incremental method be added DEXTROSE ANHYDROUS, lactalbumin Gly-His-Lys, be uniformly mixed, be distributed into bag to get.
Embodiment 4
(1) it is weighed by prescription and examines qualified whey protein concentrate Gly-His-Lys, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl butyric acid
Calcium, corn oligopeptide powder, Sucralose；
(2) Sucralose, corn oligopeptide powder are uniformly mixed with beta-hydroxy-Beta-methyl calcium butyrate, then according to equivalent
Incremental method be added DEXTROSE ANHYDROUS, whey protein concentrate Gly-His-Lys, be uniformly mixed, be distributed into bag to get.
Embodiment 5
(1) it is weighed by prescription and examines qualified whey protein concentrate Gly-His-Lys, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl butyric acid
Calcium, corn oligopeptide powder, Aspartame, leucine, valine, isoleucine；
(2) by Aspartame, corn oligopeptide powder and beta-hydroxy-Beta-methyl calcium butyrate, leucine, valine, different bright ammonia
Acid is uniformly mixed, and DEXTROSE ANHYDROUS, whey protein concentrate Gly-His-Lys then is added according to equal increments method, is uniformly mixed, is distributed into
Bag to get.
Embodiment 6
(1) it is weighed by prescription and examines qualified sepg whey protein peptide powder, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl butyric acid
Calcium, corn oligopeptide powder, acesulfame potassium, leucine, valine, isoleucine；
(2) by acesulfame potassium, corn oligopeptide powder and beta-hydroxy-Beta-methyl calcium butyrate, leucine, valine, isoleucine
It is uniformly mixed, DEXTROSE ANHYDROUS, sepg whey protein peptide powder then is added according to equal increments method, be uniformly mixed, be distributed into bag,
To obtain the final product.
Embodiment 7
1. subject: certain geriatric nursing home old man 32, the age 65-70 years old
Test group: 16, male 8 (66.8 ± 4.0 years old age), female 8 (67.5 ± 4.1 years old age)
Control group: 16, male 8 (67.4 ± 4.5 years old age), female 8 (66.2 ± 3.6 years old age)
2. test grouping and method:
Test group: the increasing flesh solid beverage 5g of the prescription preparation of embodiment 1 adds 200ml warm water
Control group: 200ml warm water
Subject is respectively at taking increasing flesh solid beverage and warm water in 30min after meal, 2 times a day, each 1 time early, late, test
Continue 60 days, during test, subject keeps normal diet.
3. evaluation method: respectively at on-test at the end of, subject's leg speed, grip, muscle ratios are measured, to measurement
As a result statistical analysis is carried out, the comparison of front and back index is tested.
1 leg speed of table, grip, bone density, muscle ratios change corresponding number statistical result
As it can be seen from table 1 test group is significantly better than control group, explanation in leg speed, grip, muscle ratios four indices
The present invention increases flesh solid beverage and has clear improvement to the muscle relaxation phenomenon of the elderly.
The above description is only an embodiment of the present invention, is not intended to limit the scope of the invention, all to utilize this hair
Equivalent transformation made by bright description, or it is used in other relevant technical fields directly, indirectly, it is included in the present invention
Scope of patent protection in.
Claims (16)
1. a kind of solid beverage with muscle-increasing function comprising following component: PURE WHEY, DEXTROSE ANHYDROUS, beta-hydroxy-
Beta-methyl calcium butyrate, corn oligopeptide powder, sweetener.
2. increasing flesh solid beverage according to claim 1, it is characterised in that the every 100g of solid beverage includes following heavy
Measure the ingredient of part: 50-75 parts of PURE WHEY, 15-30 parts of DEXTROSE ANHYDROUS, beta-hydroxy -5-15 parts of Beta-methyl calcium butyrate, corn
Oligomeric Gly-His-Lys 0.5-5 parts, 0.02-0.2 parts of sweetener.
3. increasing flesh solid beverage according to claim 2, it is characterised in that the every 100g of solid beverage include ingredient and
Parts by weight are further are as follows: 60-70 parts of PURE WHEY, 20-25 parts of DEXTROSE ANHYDROUS, beta-hydroxy -5-10 parts of Beta-methyl calcium butyrate,
2-5 parts of corn oligopeptide powder, 0.02-0.1 parts of sweetener.
4. increasing flesh solid beverage according to claim 3, it is characterised in that the every 100g of solid beverage include ingredient and
Parts by weight are further are as follows: 60 parts of PURE WHEY, 20 parts of DEXTROSE ANHYDROUS, beta-hydroxy -10 parts of Beta-methyl calcium butyrate, corn are oligomeric
3 parts of Gly-His-Lys, 0.08 part of sweetener.
5. increasing flesh solid beverage according to claim 1, it is characterised in that the PURE WHEY is selected from condensed whey egg
One of white powder, sepg whey albumen powder, lactalbumin Gly-His-Lys are a variety of.
6. increasing flesh solid beverage according to claim 5, it is characterised in that the PURE WHEY preferred whey protein peptides
Powder.
7. increasing flesh solid beverage according to claim 1, it is characterised in that the sweetener can be selected from Sucralose, A Si
Ba Tian or acesulfame potassium.
8. increasing flesh solid beverage according to claim 7, it is characterised in that the preferred Sucralose of sweetener.
9. solid beverage according to claim 1, it is characterised in that include branched-chain amino acid 2-4 in the solid beverage
Part.
10. increasing flesh solid beverage according to claim 9, it is characterised in that preferred branched-chain amino acid in the solid beverage
3 parts.
11. increasing flesh solid beverage according to claim 10, it is characterised in that the branched-chain amino acid is by valine, bright ammonia
It is formed in acid and isoleucine.
12. increasing flesh solid beverage according to claim 11, it is characterised in that leucine in the branched-chain amino acid: figured silk fabrics ammonia
Acid: the weight ratio of isoleucine is 2: 1: 1.
13. a kind of preparation method of the solid beverage with muscle-increasing function described in claim 1, it is characterised in that preparation step is such as
Under:
(1) weighing by prescription examines qualified PURE WHEY, DEXTROSE ANHYDROUS, beta-hydroxy-Beta-methyl calcium butyrate, corn oligomeric
Gly-His-Lys, sweetener；
(2) sweetener, corn oligopeptide powder are uniformly mixed with beta-hydroxy-Beta-methyl calcium butyrate, then according to equal increments method
Be added DEXTROSE ANHYDROUS, PURE WHEY, be uniformly mixed, be distributed into bag to get.
14. a kind of preparation method with muscle-increasing function solid beverage described in claim 13, it is characterised in that environment when mixing
18-25 DEG C of temperature, humidity≤50%.
15. increasing the usage and dosage of flesh solid beverage as described in claim 1: 1 total 5g is dissolved in the warm water of about 200ml, ox every time
Milk is eaten in meal, 1-2 times daily.
16. a kind of increasing flesh health food, it is characterised in that be added in increasing flesh solid beverage described in claim 1 a kind of or more
Acceptable excipient on kind food, is made hard capsule, soft capsule, pressed candy or oral solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910110553.5A CN109744449A (en) | 2019-01-23 | 2019-01-23 | A kind of increasing flesh solid beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910110553.5A CN109744449A (en) | 2019-01-23 | 2019-01-23 | A kind of increasing flesh solid beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109744449A true CN109744449A (en) | 2019-05-14 |
Family
ID=66407464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910110553.5A Pending CN109744449A (en) | 2019-01-23 | 2019-01-23 | A kind of increasing flesh solid beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109744449A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112155057A (en) * | 2020-08-25 | 2021-01-01 | 石家庄君乐宝乳业有限公司 | High-protein thickened modified milk powder and preparation method thereof |
| CN113367349A (en) * | 2020-02-25 | 2021-09-10 | 内蒙古蒙牛乳业（集团）股份有限公司 | Composition for sarcopenia, preparation method and application thereof |
| CN113974160A (en) * | 2021-11-05 | 2022-01-28 | 广州白云山敬修堂药业股份有限公司 | Composition for preventing and improving muscle attenuation and application thereof |
| CN114431380A (en) * | 2022-02-25 | 2022-05-06 | 广东君悦营养医学有限公司 | Protein water suitable for muscle attenuation syndrome and preparation method thereof |
| CN115462523A (en) * | 2022-08-24 | 2022-12-13 | 仁和全域(上海)大健康研究院有限公司 | Composition for improving athletic ability and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524155A (en) * | 2009-04-20 | 2009-09-09 | 北京康比特体育科技股份有限公司 | Amino acid composition |
| CN101791127A (en) * | 2010-03-05 | 2010-08-04 | 北京康比特体育科技股份有限公司 | Muscle protection composite containing HMbeta |
| CN106072573A (en) * | 2016-07-05 | 2016-11-09 | 郑州和正生物科技有限公司 | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible |
| CN106387586A (en) * | 2016-08-31 | 2017-02-15 | 宣城柏维力生物工程有限公司 | Whey protein and beta-hydroxy-methyl butyrate sport drink and production technology thereof |
| CN109222103A (en) * | 2018-11-29 | 2019-01-18 | 汤臣倍健股份有限公司 | Increase flesh composition and health food |
-
2019
- 2019-01-23 CN CN201910110553.5A patent/CN109744449A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524155A (en) * | 2009-04-20 | 2009-09-09 | 北京康比特体育科技股份有限公司 | Amino acid composition |
| CN101791127A (en) * | 2010-03-05 | 2010-08-04 | 北京康比特体育科技股份有限公司 | Muscle protection composite containing HMbeta |
| CN106072573A (en) * | 2016-07-05 | 2016-11-09 | 郑州和正生物科技有限公司 | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible |
| CN106387586A (en) * | 2016-08-31 | 2017-02-15 | 宣城柏维力生物工程有限公司 | Whey protein and beta-hydroxy-methyl butyrate sport drink and production technology thereof |
| CN109222103A (en) * | 2018-11-29 | 2019-01-18 | 汤臣倍健股份有限公司 | Increase flesh composition and health food |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113367349A (en) * | 2020-02-25 | 2021-09-10 | 内蒙古蒙牛乳业（集团）股份有限公司 | Composition for sarcopenia, preparation method and application thereof |
| CN113367349B (en) * | 2020-02-25 | 2024-03-12 | 内蒙古蒙牛乳业（集团）股份有限公司 | Composition for muscle wasting syndrome, preparation method and application thereof |
| CN112155057A (en) * | 2020-08-25 | 2021-01-01 | 石家庄君乐宝乳业有限公司 | High-protein thickened modified milk powder and preparation method thereof |
| CN113974160A (en) * | 2021-11-05 | 2022-01-28 | 广州白云山敬修堂药业股份有限公司 | Composition for preventing and improving muscle attenuation and application thereof |
| CN114431380A (en) * | 2022-02-25 | 2022-05-06 | 广东君悦营养医学有限公司 | Protein water suitable for muscle attenuation syndrome and preparation method thereof |
| CN115462523A (en) * | 2022-08-24 | 2022-12-13 | 仁和全域(上海)大健康研究院有限公司 | Composition for improving athletic ability and preparation method and application thereof |
| CN115462523B (en) * | 2022-08-24 | 2024-05-14 | 仁和全域(上海)大健康研究院有限公司 | Composition for improving exercise capacity as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109744449A (en) | A kind of increasing flesh solid beverage | |
| CN103766696B (en) | A kind of composition and method of making the same with muscle-increasing function | |
| Lawrence et al. | Maintenance energy cost of pregnancy in rural Gambian women and influence of dietary status | |
| CN103829140A (en) | Cereal powder with functions of losing weight and reducing blood sugar | |
| CN103190630A (en) | Functional protein powder containing conjugated linoleic acid glycerides | |
| CN104168779A (en) | Dietary supplement | |
| CN107996975A (en) | A kind of quinoa weight losing meal-replacing powder containing burdock polysaccharide | |
| Naclerio et al. | Effects of protein–carbohydrate supplementation on immunity and resistance training outcomes: a double-blind, randomized, controlled clinical trial | |
| CN110338427A (en) | A kind of peptide marrow powder and preparation method thereof | |
| CN101416743B (en) | Potentilla anserina L. rice flour food and production method thereof | |
| Steyn et al. | Anthropometric profile of the coloured population of the Cape Peninsula | |
| CN113367349B (en) | Composition for muscle wasting syndrome, preparation method and application thereof | |
| CN109430664A (en) | A kind of strong core peptide solid beverage | |
| CN107156233A (en) | A kind of low sugar mixed nuts roast pork moon cake and preparation method thereof | |
| CN107549614A (en) | Three high meals powder and preparation method thereof are nursed one's health in a kind of dietotherapy | |
| Iddrisu et al. | The effect of dandelion leaves and roots on blood glucose in type 2 diabetic patients | |
| CN111000257A (en) | Diet for losing weight and preparation method thereof | |
| CN104887739A (en) | Angelica sinensis-astragalus membranaceus blood replenishing oral tablets, as well as preparation method and application thereof | |
| US4230695A (en) | Enhanced protein assimilation with fructose | |
| CN109430667A (en) | A kind of composition and solid beverage with anti-trioxypurine effect | |
| CN110403166A (en) | A kind of energy food and preparation method thereof | |
| CN108651833A (en) | A kind of low sugar sweet corn can and preparation method thereof | |
| CN105055625B (en) | A kind of Chinese herbal medicine extract and application thereof | |
| CN108653647A (en) | Food and medicine consangunity health composition and preparation method thereof | |
| CN117899179A (en) | Traditional Chinese medicine compound preparation for treating overweight or obesity and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: GUANGZHOU OUPUKANG SPECIAL MEDICAL FOOD CO.,LTD. Person in charge of patents Document name: Notice of First Examination Opinion |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: GUANGZHOU OUPUKANG SPECIAL MEDICAL FOOD CO.,LTD. Person in charge of patents Document name: Deemed withdrawal notice |
|
| DD01 | Delivery of document by public notice | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190514 |
|
| WD01 | Invention patent application deemed withdrawn after publication |